StonvexLoading…
StonvexStonvexStonvexCore line items from WBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $63.69M | $237.97M | $179.27M | $120.21M |
Operating Income | $356.76M | $1.47B | $1.11B | $731.28M |
Net Income | $246.23M | $1.00B | $746.98M | $485.76M |
EPS (Diluted) | $1.50 | $5.90 | $4.36 | $2.81 |
Total Assets | $85.58B | $84.07B | $83.19B | $81.91B |
Total Liabilities | $76.01B | $74.58B | $73.73B | $72.58B |
Cash & Equivalents | $2.86B | $2.45B | $3.06B | $2.99B |
Free Cash Flow OCF − CapEx | $278.27M | $1.01B | $706.78M | $344.27M |
Shares Outstanding | 162.05M | 161.22M | 164.82M | 167.08M |